Paget-Schroetter disease future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Angiology]] | [[Category:Angiology]] | ||
[[Category:cardiology]] | [[Category:cardiology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 16:23, 17 June 2020
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Paget-Schroetter disease future or investigational therapies On the Web |
American Roentgen Ray Society Images of Paget-Schroetter disease future or investigational therapies |
FDA on Paget-Schroetter disease future or investigational therapies |
CDC on Paget-Schroetter disease future or investigational therapies |
Paget-Schroetter disease future or investigational therapies in the news |
Blogs on Paget-Schroetter disease future or investigational therapies |
Risk calculators and risk factors for Paget-Schroetter disease future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: